Filter

Primary Care “Opioid Risk Scores” Poorly Predict Individual OD Risk

The first external evaluation of a cognitive-computing model widely used by health care systems found a concerning amount of ...
FierceBiotech

Tris builds clinical case for opioid alternative by showing its pain drug is less likely to be abused

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused. The phase 1 ...
ascopubs.org

Addressing Opioid-Associated Constipation Using Quality Oncology Practice Initiative Scores and Plan-Do-Study-Act Cycles

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society ...
MedPage Today

7-Day Buprenorphine Promising for Mild Opioid Withdrawal

Extended-release 7-day injectable buprenorphine was safe and tolerable for most patients who had minimal-to-mild opioid withdrawal, a nonrandomized trial found. Among 100 adult patients with ...
Healio

‘Clinical judgment’: Opioid prescriptions declining for patients with cancer without pain

Please provide your email address to receive an email when new articles are posted on . Opioids prescribing declined from 2016 to 2020 for patients with cancer in Connecticut who did not report ...

A safer opioid? DFNZ discovery suggests pain relief with minimal addictive properties

Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as ...